End-of-life care in illicit drug users: mapping medication use.

Phoebe UlrickStacey PanozzoDavid MarcoAnna CollinsJennifer A M Philip
Published in: BMJ supportive & palliative care (2021)
Results suggest that PWUD require greater doses of symptom-controlling medications, particularly opioids and midazolam, at the end of life but that rates of dose escalation do not differ greatly. This study provides a foundation for future research to inform clinical guidelines for this cohort of palliative care patients.